Published in Blood Weekly, July 26th, 2001
"Toxicities have limited the use of allogeneic hematopoietic cell transplantation (HCT) to younger, medically fit patients," explained Peter A. McSweeney and colleagues at the University of Colorado and other institutions.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.